Insights

Global Distribution Inmunotek sells products in Spain and over 50 other countries via subsidiaries, sales offices, and exclusive distributors, indicating a broad partner network and multiple regional entry points for new solutions.

Therapeutic Vaccines The company focuses on therapeutic vaccines for allergies, infectious diseases, and cancer, presenting opportunities to cross-sell companion diagnostics, delivery devices, and related immunotherapy support services to healthcare providers and payers.

Manufacturing Footprint Two GMP-certified production centers in Madrid suggest capacity for scale-up, contract manufacturing partnerships, and rapid clinical-to-commercial manufacturing collaborations for new vaccine programs.

R&D Funding Recent CDTI E.P.E. funding approval for a novel immunotherapy project signals active government-backed innovation and potential for co-development opportunities and grant-aligned partnerships.

Digital & Data Capabilities Tech stack includes Power Platform, Salesforce, SQL/PostgreSQL, and OpenAI, highlighting readiness for advanced customer relationship management, data-driven sales initiatives, and AI-enabled market analytics.

Similar companies to Inmunotek

GenScript
1.4K$500M - $1B
JPT Peptide Technologies
80$10M - $25M
Scytek Laboratories
15$1M - $10M
PeproTech, now part of Thermo Fisher Scientific
61$25M - $50M
Thermo Fisher Scientific
96K$10B+
BioLegend
653$250M - $500M
RayBiotech
63$25M - $50M
AnaSpec
100$25M - $50M

Inmunotek Tech Stack

Inmunotek uses 8 technology products and services including Microsoft Power Automate, Microsoft Power Platform, Salesforce, and more. Explore Inmunotek's tech stack below.

Microsoft Power Automate
Build Automation
Microsoft Power Platform
Business Intelligence
Salesforce
Customer Relationship Management
Microsoft SQL Server
Database
PostgreSQL
Database
Shopify
E-commerce
OpenAI
Generative Ai
Google Cloud
Infrastructure As A Service

Media & News

Inmunotek's Email Address Formats

Inmunotek uses at least 3 email formats:

Inmunotek Email Formats	Example	Percentage
FLast@inmunotek.com	JDoe@inmunotek.com	80%
FMLast@inmunotek.com	JMDoe@inmunotek.com	19%
First@inmunotek.com	John@inmunotek.com	1%

Frequently Asked Questions

What is Inmunotek's official website and social media links?

Inmunotek's official website is inmunotek.com and has social profiles on LinkedIn.

How much revenue does Inmunotek generate?

As of October 2026, Inmunotek's annual revenue is estimated to be $50M - $100M.

What is Inmunotek's NAICS code?

Inmunotek's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Inmunotek have currently?

As of October 2026, Inmunotek has approximately 377 employees across 5 continents, including Europe, South America and North America. Key team members include Ceo-Presidente: J. L. S., President: J. B. and Head Of Regulatory Affairs: P. G. F. Explore Inmunotek's employee directory with LeadIQ.

What industry does Inmunotek belong to?

Inmunotek operates in the Pharmaceutical Manufacturing industry.

What technology does Inmunotek use?

Inmunotek's tech stack includes Microsoft Power Automate, Microsoft Power Platform, Salesforce, Microsoft SQL Server, PostgreSQL, Shopify, OpenAI and Google Cloud.

What is Inmunotek's email format?

Inmunotek's email format typically follows the pattern of FLast@inmunotek.com. Find more Inmunotek email formats with LeadIQ.

When was Inmunotek founded?

Inmunotek was founded in 1992.

Inmunotek

Q: What is Inmunotek's official website and social media links?

Inmunotek's official website is inmunotek.com. Inmunotek has social profiles on LinkedIn.

Q: How many employees does Inmunotek have currently?

Inmunotek has approximately 377 employees.

Q: What technology does Inmunotek use?

Inmunotek's tech stack includes Microsoft, TweenMax, WPBakery, Lightbox, PHP.

Q: What is Inmunotek's NAICS code?

Inmunotek's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingCommunity of Madrid, Spain201-500 Employees

Inmunotek is a pharmaceutical company focused on researching, developing, manufacturing, and distributing therapeutic vaccines for allergies, infectious diseases, and cancer, and it also produces medical devices. The firm serves Spain and more than 50 other countries through its subsidiaries, sales offices, and exclusive distributors. It operates two GMP-certified production centers in San Sebastián de los Reyes and Alcalá de Henares, both located in the Community of Madrid. Founded in 1992, Inmunotek is based in the Community of Madrid.

The company has been named one of Europe’s Long-Term Growth Champions in a Financial Times ranking. In 2019, Inmunotek announced the development of an Expanded Access Program for the unlicensed bacterial vaccine Uromune (MV140).